US Stock MarketDetailed Quotes

PSTX Poseida Therapeutics

Watchlist
  • 9.310
  • -0.020-0.21%
Close Nov 29 13:00 ET
  • 9.300
  • -0.010-0.11%
Post 17:01 ET
907.41MMarket Cap-14777P/E (TTM)

Poseida Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
667.19%71.75M
29.78%25.97M
172.09%28.14M
-50.42%64.7M
148.68%25M
-91.96%9.35M
641.22%20.01M
620.77%10.34M
317.73%130.49M
-67.82%10.05M
Operating revenue
667.19%71.75M
29.78%25.97M
172.09%28.14M
-50.42%64.7M
148.68%25M
-91.96%9.35M
641.22%20.01M
620.77%10.34M
317.73%130.49M
-67.82%10.05M
Cost of revenue
Gross profit
Operating expense
14.11%52.01M
20.60%57.73M
5.74%52.72M
1.98%194.21M
17.64%50.9M
2.35%45.57M
8.19%47.87M
-14.62%49.86M
10.30%190.44M
-11.17%43.27M
Selling and administrative expenses
24.72%10.09M
40.41%12.18M
-17.02%9.8M
-0.28%37.44M
-5.43%8.86M
-13.81%8.09M
-6.07%8.68M
23.69%11.81M
4.52%37.54M
-2.51%9.37M
-General and administrative expense
24.72%10.09M
40.41%12.18M
-17.02%9.8M
-0.28%37.44M
-5.43%8.86M
-13.81%8.09M
-6.07%8.68M
23.69%11.81M
4.52%37.54M
-2.51%9.37M
Research and development costs
11.82%41.91M
16.22%45.55M
12.80%42.92M
2.53%156.77M
24.01%42.05M
6.67%37.48M
11.95%39.19M
-22.10%38.05M
11.82%152.9M
-13.30%33.9M
Operating profit
154.50%19.74M
-14.00%-31.76M
37.80%-24.58M
-116.03%-129.5M
22.01%-25.91M
-150.46%-36.22M
32.95%-27.86M
30.63%-39.52M
57.61%-59.95M
-90.07%-33.22M
Net non-operating interest income expense
-2.64%-2.3M
-5.51%-2.26M
-11.09%-2.25M
-36.12%-8.67M
-14.78%-2.27M
-25.97%-2.24M
-38.76%-2.14M
-88.30%-2.03M
-89.70%-6.37M
-135.12%-1.98M
Non-operating interest expense
2.64%2.3M
5.51%2.26M
11.09%2.25M
36.12%8.67M
14.78%2.27M
25.97%2.24M
38.76%2.14M
88.30%2.03M
89.70%6.37M
135.12%1.98M
Other net income (expense)
-58.29%2.83M
4.09%2.64M
-5.23%2.56M
419.66%14.85M
30.28%2.83M
934.60%6.79M
4,784.62%2.54M
14,294.74%2.7M
-85.56%2.86M
-89.03%2.17M
Other non- operating income (expenses)
-58.29%2.83M
4.09%2.64M
-5.23%2.56M
419.66%14.85M
30.28%2.83M
934.60%6.79M
4,784.62%2.54M
14,294.74%2.7M
-85.56%2.86M
-89.03%2.17M
Income before tax
164.03%20.28M
-14.26%-31.37M
37.51%-24.27M
-94.34%-123.32M
23.25%-25.35M
-144.82%-31.67M
36.20%-27.46M
33.09%-38.85M
49.22%-63.46M
-2,348.20%-33.03M
Income tax
-59.81%43K
-80.33%107K
0
-57.54%107K
544K
292K
Net income
163.68%20.24M
-14.26%-31.37M
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
Net income continuous Operations
163.68%20.24M
-14.26%-31.37M
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
Minority interest income
Net income attributable to the parent company
163.68%20.24M
-14.26%-31.37M
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
163.68%20.24M
-14.26%-31.37M
37.51%-24.27M
-92.85%-123.43M
23.92%-25.35M
-145.13%-31.78M
36.20%-27.46M
33.09%-38.85M
48.79%-64M
-2,368.07%-33.32M
Basic earnings per share
160.00%0.21
0.00%-0.32
44.44%-0.25
-53.93%-1.37
33.33%-0.26
-138.04%-0.35
53.62%-0.32
51.61%-0.45
55.72%-0.89
-2,050.00%-0.39
Diluted earnings per share
160.00%0.21
0.00%-0.32
44.44%-0.25
-53.93%-1.37
33.33%-0.26
-138.04%-0.35
53.62%-0.32
51.61%-0.45
55.72%-0.89
-2,050.00%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 667.19%71.75M29.78%25.97M172.09%28.14M-50.42%64.7M148.68%25M-91.96%9.35M641.22%20.01M620.77%10.34M317.73%130.49M-67.82%10.05M
Operating revenue 667.19%71.75M29.78%25.97M172.09%28.14M-50.42%64.7M148.68%25M-91.96%9.35M641.22%20.01M620.77%10.34M317.73%130.49M-67.82%10.05M
Cost of revenue
Gross profit
Operating expense 14.11%52.01M20.60%57.73M5.74%52.72M1.98%194.21M17.64%50.9M2.35%45.57M8.19%47.87M-14.62%49.86M10.30%190.44M-11.17%43.27M
Selling and administrative expenses 24.72%10.09M40.41%12.18M-17.02%9.8M-0.28%37.44M-5.43%8.86M-13.81%8.09M-6.07%8.68M23.69%11.81M4.52%37.54M-2.51%9.37M
-General and administrative expense 24.72%10.09M40.41%12.18M-17.02%9.8M-0.28%37.44M-5.43%8.86M-13.81%8.09M-6.07%8.68M23.69%11.81M4.52%37.54M-2.51%9.37M
Research and development costs 11.82%41.91M16.22%45.55M12.80%42.92M2.53%156.77M24.01%42.05M6.67%37.48M11.95%39.19M-22.10%38.05M11.82%152.9M-13.30%33.9M
Operating profit 154.50%19.74M-14.00%-31.76M37.80%-24.58M-116.03%-129.5M22.01%-25.91M-150.46%-36.22M32.95%-27.86M30.63%-39.52M57.61%-59.95M-90.07%-33.22M
Net non-operating interest income expense -2.64%-2.3M-5.51%-2.26M-11.09%-2.25M-36.12%-8.67M-14.78%-2.27M-25.97%-2.24M-38.76%-2.14M-88.30%-2.03M-89.70%-6.37M-135.12%-1.98M
Non-operating interest expense 2.64%2.3M5.51%2.26M11.09%2.25M36.12%8.67M14.78%2.27M25.97%2.24M38.76%2.14M88.30%2.03M89.70%6.37M135.12%1.98M
Other net income (expense) -58.29%2.83M4.09%2.64M-5.23%2.56M419.66%14.85M30.28%2.83M934.60%6.79M4,784.62%2.54M14,294.74%2.7M-85.56%2.86M-89.03%2.17M
Other non- operating income (expenses) -58.29%2.83M4.09%2.64M-5.23%2.56M419.66%14.85M30.28%2.83M934.60%6.79M4,784.62%2.54M14,294.74%2.7M-85.56%2.86M-89.03%2.17M
Income before tax 164.03%20.28M-14.26%-31.37M37.51%-24.27M-94.34%-123.32M23.25%-25.35M-144.82%-31.67M36.20%-27.46M33.09%-38.85M49.22%-63.46M-2,348.20%-33.03M
Income tax -59.81%43K-80.33%107K0-57.54%107K544K292K
Net income 163.68%20.24M-14.26%-31.37M37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M
Net income continuous Operations 163.68%20.24M-14.26%-31.37M37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M
Minority interest income
Net income attributable to the parent company 163.68%20.24M-14.26%-31.37M37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 163.68%20.24M-14.26%-31.37M37.51%-24.27M-92.85%-123.43M23.92%-25.35M-145.13%-31.78M36.20%-27.46M33.09%-38.85M48.79%-64M-2,368.07%-33.32M
Basic earnings per share 160.00%0.210.00%-0.3244.44%-0.25-53.93%-1.3733.33%-0.26-138.04%-0.3553.62%-0.3251.61%-0.4555.72%-0.89-2,050.00%-0.39
Diluted earnings per share 160.00%0.210.00%-0.3244.44%-0.25-53.93%-1.3733.33%-0.26-138.04%-0.3553.62%-0.3251.61%-0.4555.72%-0.89-2,050.00%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data